Injection carbetocin vs Injection oxytocin in reduction Of postpartum blood loss in Caesarean section- a randomized Controlled trial.

Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1823

Full metadata record

DC Field	Value	Language
dc.contributor.author	REG.NO:BJ0121018	-
dc.date.accessioned	2025-04-27T08:52:16Z	-
dc.date.available	2025-04-27T08:52:16Z	-
dc.date.issued	2024	-
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/1823	-
dc.description.abstract	Introduction: Postpartum haemorrhage is one of the leading causes of maternal mortality, accounting for 35% of maternal deaths worldwide. The focal point of prevention of PPH is the use of uterotonic drugs immediately after birth of new born. Oxytocin is most widely accepted uterotonic agent and standard therapy for the prevention of postpartum haemorrhage over years. Use of Heat Stable Carbetocin is also recommended and has added advantages. Major advantage of Heat Stable Carbetocin is that formulation is heat stable and useful in countries where cold chain is unreliable. Objective: 1. To find out effectiveness of Inj. Oxytocin vs Inj. Heat Stable Carbetocin in reduction of postpartum blood loss in caesarean section	en_US
dc.language.iso	en_US	en_US
dc.publisher	KLE Academy of Higher Education and Research, Belagavi	en_US
dc.subject	Uterotonics, Heat Stable Carbetocin, Caesarean section	en_US
dc.title	Injection carbetocin vs Injection oxytocin in reduction Of postpartum blood loss in Caesarean section- a randomized Controlled trial.	en_US
dc.type	Dissertations	en_US
Appears in Collections:	Obstetrics & Gynaecology MS

Files in This Item:

File	Description	Size	Format
BJ0121018.pdf		6 MB	Adobe PDF	View/Open